Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
Clinical trial NCT01600716 · COMPLETED
Trial details
- NCT number
- NCT01600716
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-13
- Primary completion
- 2014-04-04
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.